Yael Capital Management Limited

Yael Capital Management Limited is a venture capital and private equity firm investing in early-stage biotechnology companies that is headquartered in China and was founded in 2018. The firm typically makes early-stage investments in biotechnology and biopharma technology companies.

On October 25, 2018 Yael Capital Management Limited participated in a $46 million series B extension funding round with SIG and China Life Healthcare in XtalPi, a biotechnology and artificial intelligence company developing a drug discovery platform.